Acuta Capital Partners, LLC Clearside Biomedical, Inc. Transaction History

Acuta Capital Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.72 - $5.72 $3.58 Million - $7.53 Million	-1,316,268 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.32 - $5.38 $690,738 - $1.6 Million	-297,732 Reduced 18.45%	1,316,268 $6.41 Million
Q1 2021 May 17, 2021	BUY	$2.24 - $4.25 $815,360 - $1.55 Million	364,000 Added 29.12%	1,614,000 $3.99 Million
Q4 2020 Feb 16, 2021	BUY	$1.32 - $2.74 $838,200 - $1.74 Million	635,000 Added 103.25%	1,250,000 $3.43 Million
Q3 2020 Nov 16, 2020	BUY	$1.45 - $2.0 $891,750 - $1.23 Million	615,000 New	615,000 $947,000

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $62M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.